ASCI Code vs CPA: Advertising Regulation in India Explained

Advertising in India is regulated through a dual framework: ASCI's voluntary self-regulatory code and statutory enforcement under the Consumer Protection Act, 2019. While ASCI directs ad modifications or withdrawals, the Central Consumer Protection Authority (CCPA) holds statutory authority to levy heavy monetary fines on advertisers, manufacturers, and endorsers.

ASCI Code vs CPA: Advertising Regulation in India Explained

Advertising Standards and the ASCI Code: Self-Regulation vs Legal Enforcement

Advertisements in India are subject to a layered system of oversight, combining the Advertising Standards Council of India's self-regulatory code with binding statutory enforcement under consumer protection law, and understanding how these two mechanisms interact helps both consumers and advertisers gauge the actual consequences of a misleading advertisement.

The ASCI Code and Its Self-Regulatory Nature

The Advertising Standards Council of India, a voluntary self-regulatory body of the advertising industry, administers a code requiring advertisements to be truthful, not offend generally accepted standards of decency, and avoid causing harm to consumers, particularly children, with complaints examined by ASCI's Consumer Complaints Council, which can direct modification or withdrawal of a non-compliant advertisement, though ASCI itself lacks direct statutory power to impose fines or penalties.

Statutory Backing Through the Consumer Protection Act

The Consumer Protection Act, 2019, gives misleading advertisements binding legal consequences by empowering the Central Consumer Protection Authority to investigate, direct discontinuation, and impose monetary penalties on manufacturers, advertisers, and endorsers, meaning advertisements that would previously have faced only ASCI's advisory action can now attract direct regulatory penalties, including penalties running into lakhs of rupees for repeated violations.

Role of Sector-Specific Regulators

Certain categories of advertisements, including those for pharmaceuticals, financial products, and food items, additionally fall under sector-specific regulatory oversight such as the Drugs and Magic Remedies Act, RBI advertising guidelines for financial products, and FSSAI labelling regulations, meaning a single misleading advertisement can potentially attract scrutiny from multiple regulatory bodies simultaneously depending on the product category involved.

Consumer Remedies for Misleading Advertisements

A consumer who purchases a product based on a misleading advertisement and suffers loss as a result retains the option of filing a complaint with ASCI for industry-level action, a complaint with the Central Consumer Protection Authority for regulatory penalties, and a separate consumer complaint before a consumer forum seeking individual compensation, with these three avenues operating independently and capable of being pursued together depending on the consumer's objective.

Practical Guidance for Advertisers

Businesses developing advertising campaigns are advised to ensure claims are substantiated with credible evidence before publication, particularly for comparative and superiority claims, verify that any endorser has genuinely used the product where such use is implied, and review advertisements against both the ASCI Code and applicable sector-specific regulations, since compliance with one framework does not guarantee compliance with the other.

Frequently Asked Questions

Can ASCI impose a fine on an advertiser for a misleading advertisement?
ASCI, as a self-regulatory body, can direct modification or withdrawal of a non-compliant advertisement but lacks direct statutory power to impose fines, unlike the Central Consumer Protection Authority.

Can a consumer claim compensation for a purchase made based on a misleading ad?
A consumer who suffers loss from a misleading advertisement can pursue individual compensation before a consumer forum, separate from any regulatory action taken by ASCI or the CCPA.

Are pharmaceutical advertisements regulated separately from general advertisements?
Pharmaceutical advertisements fall under the specific oversight of the Drugs and Magic Remedies Act in addition to the general ASCI Code and Consumer Protection Act framework.

Can the same misleading advertisement face action from multiple bodies?
A single misleading advertisement can attract scrutiny from ASCI, the Central Consumer Protection Authority, and relevant sector-specific regulators simultaneously, depending on the product category.

 

Need Legal Advice?
Your first consultation is absolutely free. Talk to our expert team and get guidance for your case today.
← Back to Blogs
Your first consultation is free!
Get expert advice from our team.